Business Daily.
.
A+ R A-

Lumos Pharma Receives Wellcome Trust Award for Advancing Potential Treatment of Creatine Transporter Deficiency (CTD)

E-mail Print PDF
Lumos Pharma, Inc. (Austin, Texas) announced today that it has received an award of up to $5.5 million from the Translation Fund of the Wellcome Trust.
Grow Your Business with Times Media
Business Daily Media